Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tela Bio Inc (TELA)

Tela Bio Inc (TELA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 184,373
  • Shares Outstanding, K 14,472
  • Annual Sales, $ 18,210 K
  • Annual Income, $ -28,790 K
  • 60-Month Beta 1.92
  • Price/Sales 10.82
  • Price/Cash Flow N/A
  • Price/Book 5.38
Trade TELA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.51
  • Number of Estimates 2
  • High Estimate -0.44
  • Low Estimate -0.59
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +3.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.90 +7.06%
on 09/14/21
14.25 -10.60%
on 08/23/21
-1.14 (-8.21%)
since 08/20/21
3-Month
11.90 +7.06%
on 09/14/21
16.53 -22.91%
on 06/25/21
-2.26 (-15.07%)
since 06/18/21
52-Week
11.03 +15.50%
on 05/13/21
18.00 -29.22%
on 02/24/21
-2.65 (-17.22%)
since 09/18/20

Most Recent Stories

More News
TELA Bio(R) Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique

TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue...

TELA : 12.74 (-6.46%)
Recent Developments in Soft Tissue Reconstruction to be Explored on an Upcoming Episode of Advancements

/PRNewswire-PRWeb/ -- Scheduled to broadcast 4Q/2021, Advancements with will focus on breakthroughs in soft tissue repair solutions. Check local listings for more information.

TELA : 12.74 (-6.46%)
TELA Bio, Inc. (TELA) Reports Q2 Loss, Tops Revenue Estimates

TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of -16.33% and 18.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

TELA : 12.74 (-6.46%)
TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

TELA Bio, Inc. (TELA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TELA : 12.74 (-6.46%)
New Strong Sell Stocks for June 18th

OEG, EAF, RARE, EGRX, and TELA have been added to the Zacks Rank #5 (Strong Sell) List on June 18, 2021

RARE : 96.44 (-1.86%)
EGRX : 49.03 (-0.51%)
EAF : 10.21 (-2.58%)
TELA : 12.74 (-6.46%)
OEG : 2.92 (-5.81%)
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates

TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of -27.27% and 4.02%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

TELA : 12.74 (-6.46%)
TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

TELA Bio, Inc. (TELA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TELA : 12.74 (-6.46%)
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates

TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of -5.88% and 1.20%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

TELA : 12.74 (-6.46%)
TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development

Bruce Freedman, M.D. joins innovative MedTech company to advocate for more natural surgical hernia mesh options

MHMNF : 54.5000 (unch)
TELA : 12.74 (-6.46%)
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results

--Record FY2019 New Debt and Equity Commitments of $1.47 Billion, up 21.6% Year-over-Year

TELA : 12.74 (-6.46%)
MYOV : 22.11 (-3.15%)
UROV : 16.24 (+0.06%)
HTGC : 16.50 (-1.67%)
HCXZ : 25.20 (unch)
HCXY : 26.70 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 14.11
2nd Resistance Point 13.74
1st Resistance Point 13.24
Last Price 12.74
1st Support Level 12.37
2nd Support Level 12.00
3rd Support Level 11.50

See More

52-Week High 18.00
Fibonacci 61.8% 15.34
Fibonacci 50% 14.51
Fibonacci 38.2% 13.69
Last Price 12.74
52-Week Low 11.03

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar